Clinical Trial: Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis
Brief Summary: The aim of this study was to evaluate the efficacy and safety of the prophylactic effect of intracameral moxifloxacin for prevention of postcataract endophthalmitis.
Detailed Summary:
Although cataract surgery is generally considered a safe procedure resulting in a favourable visual outcome, surgical complications do occur. The most feared complication is postoperative endophthalmitis which is an infectious condition caused by micro-organisms introduced to the interior of the eye during or after the surgical procedure.
As endophthalmitis is an infection, it should be preventable by antibiotic treatment.
Prophylactic antibiotic treatment can be given as topical treatment preoperatively, or during surgery directly into the anterior chamber, or as a subconjunctival, or it can be given as topical treatment postoperatively.
The aim of this study was to evaluate the efficacy and safety of the prophylactic effect of intracameral moxifloxacin for prevention of postcataract endophthalmitis.
Sponsor: Universidade Federal de Pernambuco
Current Primary Outcome: endothelial cell count [ Time Frame: 6-month; 1 year; 2 years ]
Original Primary Outcome: endothelial cell count [ Time Frame: 1 year ]
Current Secondary Outcome: endophthalmitis incidence [ Time Frame: 1 month ]
Original Secondary Outcome: Same as current
Information By: Universidade Federal de Pernambuco
Dates:
Date Received: November 2, 2015
Date Started: January 2013
Date Completion: December 2017
Last Updated: May 1, 2017
Last Verified: May 2017
